83 studies found for:    "gene therapy" OR "gene transfer" OR "virus delivery" | adenovirus
Show Display Options
Rank Status Study
1 Completed Gene Therapy in Treating Women With Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Biological: adenovirus-mediated human interleukin-12
2 Completed Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Transplantation
Intervention: Genetic: ADV-TK (adenovirus-thymidine kinase enzyme) gene therapy
3 Completed Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: adenovirus RSV-TK;   Drug: ganciclovir
4 Terminated Phase I Study of Adenoviral Vector Mediated Gene Transfer for Ornithine Transcarbamylase in Adults With Partial Ornithine Transcarbamylase Deficiency
Condition: Ornithine Transcarbamylase Deficiency Disease
Intervention: Genetic: Adenoviral Vector-Mediated Gene Transfer
5 Active, not recruiting Gene Therapy for Pleural Malignancies
Conditions: Pleural Mesothelioma;   Metastatic Pleural Effusions
Interventions: Biological: Adenoviral-mediated Interferon-beta;   Biological: SCH 721015
6 Recruiting Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: Theragene®,Ad5-yCD/mutTKSR39rep-ADP
7 Completed A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers
Condition: Ovarian Cancer
Interventions: Genetic: Ad5.SSTR/TK.RGD;   Drug: Ganciclovir (GCV)
8 Not yet recruiting p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma
Conditions: HCC;   Diabetes
Interventions: Drug: p53 gene therapy;   Drug: Trans-catheter embolization
9 Recruiting Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer
Condition: Prostate Cancer
Intervention: Biological: Ad5-yCD/mutTKSR39rep-hIL12
10 Completed Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: recombinant adenovirus-p53 SCH-58500;   Procedure: conventional surgery
11 Completed TK-based Suicide Gene Therapy for Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Genetic: TK99UN
12 Terminated Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma
Condition: Pancreatic Cancer
Intervention: Genetic: Ad5-yCD/mutTKSR39rep-ADP
13 Completed Intrapleural Gene Transfer for Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Biological: SCH 721015
14 Active, not recruiting Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Condition: Cancer
Intervention: Biological: recombinant adenovirus-hIFN-beta
15 Active, not recruiting Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF)
Condition: Melanoma
Intervention: Biological: Autologous, lethally irradiated melanoma cells
16 Completed Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy
Conditions: Coronary Artery Disease;   Ischemia
Intervention:
17 Completed Gene Therapy in Treating Patients With Advanced Bladder Cancer
Conditions: Recurrent Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Intervention: Biological: Ad5CMV-p53 gene
18 Terminated Gene Therapy in Treating Patients With Cancer of The Liver
Condition: Liver Cancer
Intervention: Biological: Ad5CMV-p53 gene
19 Terminated Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase Deficiency
Condition: Ornithine Transcarbamylase Deficiency Disease
Intervention: Genetic: recombinant adenovirus containing the ornithine transcarbamylase gene
20 Not yet recruiting Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion
Condition: Malignant Pleural Effusion
Interventions: Drug: rAdp53;   Drug: Cisplatin;   Drug: rAdp53 plus cisplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.